¼ÓÈëÊÕ²Ø | ÉèÖÃÊ×Ò³
 ¸ß¼¶ËÑË÷
ÊÞÒ©¹ÜÀíÌõÀýÖÐÓ¢ÎĶÔÕÕ    A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

ÊÞÒ©¹ÜÀíÌõÀýÖÐÓ¢ÎĶÔÕÕ

£¨Ò»£©ÒÔ·ÇÊÞҩð³äÊÞÒ©»òÕßÒÔËûÖÖÊÞҩð³ä´ËÖÖÊÞÒ©µÄ£»    (1) a non-veterinary drug substance is passed off as a veterinary drug or one veterinary drug is passed off as another; or
£¨ËÄ£©ÊÞÒ©µÄ±êÇ©ºÍ˵Ã÷ÊéÑù±¾£»    (4) a sample copy of the label and package leaflet of the veterinary drug;
£¨Î壩ÊÞÒ©µÄÑùÆ·¡¢¶ÔÕÕÆ·¡¢±ê׼Ʒ£»    (5) a sample, reference substance and standard substance of the veterinary drug;
ÊÞÒ©¾­ÓªÐí¿ÉÖ¤ÓÐЧÆÚΪ£µÄê¡£ÓÐЧÆÚ½ìÂú£¬ÐèÒª¼ÌÐø¾­ÓªÊÞÒ©µÄ£¬Ó¦µ±ÔÚÐí¿ÉÖ¤ÓÐЧÆÚ½ìÂúÇ°£¶¸öÔµ½Ô­·¢Ö¤»ú¹ØÉêÇë»»·¢ÊÞÒ©¾­ÓªÐí¿ÉÖ¤¡£    A Veterinary Drug Distribution Licence is valid for five years. A distributor that needs to continue the distribution of veterinary drugs after the expiry date shall, six months before the expiration of the licence, apply to the original department that issued the licence for renewal of the Veterinary Drug Distribution Licence.
½ûÖ¹ÊÞÒ©¾­ÓªÆóÒµ¾­ÓªÈËÓÃÒ©Æ·ºÍ¼Ù¡¢ÁÓÊÞÒ©¡£    A veterinary drug distributor is prohibited from distributing drugs for human use, as well as counterfeit and substandard veterinary drugs.
ÊÞÒ©Éú²úÆóÒµÓ¦µ±½¨Á¢Éú²ú¼Ç¼£¬Éú²ú¼Ç¼Ӧµ±ÍêÕû¡¢×¼È·¡£    A veterinary drug manufacturer shall keep records of production, which shall be complete and accurate.
ÊÞÒ©Éú²úÐí¿ÉÖ¤ÓÐЧÆÚΪ£µÄê¡£ÓÐЧÆÚ½ìÂú£¬ÐèÒª¼ÌÐøÉú²úÊÞÒ©µÄ£¬Ó¦µ±ÔÚÐí¿ÉÖ¤ÓÐЧÆÚ½ìÂúÇ°£¶¸öÔµ½Ô­·¢Ö¤»ú¹ØÉêÇë»»·¢ÊÞÒ©Éú²úÐí¿ÉÖ¤¡£    A Veterinary Drug Manufacturing Licence is valid for five years. A manufacturer that needs to continue the production of veterinary drugs after the expiry date shall, six months before the expiration of the licence, apply to the original department that issued the licence for renewal of the Veterinary Drug Manufacturing Licence.
ÓÐÏÂÁÐÇéÐÎÖ®Ò»µÄ£¬°´ÕÕ¼ÙÊÞÒ©´¦Àí£º    A veterinary drug shall be treated as counterfeit in any of the following cases:
ÊÞÒ©³ö³§Ó¦µ±¸½ÓвúÆ·ÖÊÁ¿ºÏ¸ñÖ¤¡£    A veterinary drug that leaves the manufacturing plant shall bear a certificate of quality.
ÊÞÓÃÉúÎïÖÆÆ·½ø¿Úºó£¬Ó¦µ±ÒÀÕÕ±¾ÌõÀýµÚÊ®¾ÅÌõµÄ¹æ¶¨½øÐÐÉó²éºË¶ÔºÍ³é²é¼ìÑé¡£ÆäËûÊÞÒ©½ø¿Úºó£¬Óɵ±µØÊÞÒ½ÐÐÕþ¹ÜÀí²¿ÃÅ֪ͨÊÞÒ©¼ìÑé»ú¹¹½øÐгé²é¼ìÑé¡£    After it is imported, a veterinary biologic shall undergo verification and sampling tests in accordance with the provisions of Article 19 of these Regulations. After other veterinary drugs are imported, the local administrative department for veterinary medicine shall notify the veterinary drug test institution to conduct sampling tests.
ÊÞÒ©Èë¿â¡¢³ö¿â£¬Ó¦µ±Ö´Ðмì²éÑéÊÕÖƶȣ¬²¢ÓÐ׼ȷ¼Ç¼¡£    An inspection and acceptance system shall be implemented for placing veterinary drugs in and releasing them from the storehouse, and accurate records shall be kept in this regard.
Î¥·´±¾ÌõÀý¹æ¶¨£¬ÑÐÖÆÐÂÊÞÒ©²»¾ß±¸¹æ¶¨µÄÌõ¼þÉÃ×ÔʹÓÃÒ»Àಡԭ΢ÉúÎï»òÕßÔÚʵÑéÊҽ׶Îǰδ¾­Åú×¼µÄ£¬ÔðÁîÆäֹͣʵÑ飬²¢´¦£µÍòÔªÒÔÉÏ£±£°ÍòÔªÒÔÏ·£¿î£»¹¹³É·¸×ïµÄ£¬ÒÀ·¨×·¾¿ÐÌÊÂÔðÈΣ»¸øËûÈËÔì³ÉËðʧµÄ£¬ÒÀ·¨³Ðµ£Åâ³¥ÔðÈΡ£    Any entity that, in violation of the provisions of these Regulations, uses pathogenic microorganisms of Class I in the research and development of a new veterinary drug with no conditions required, or does so with no approval obtained prior to the laboratory stage shall be ordered to desist from the experimentation and shall, in addition, be fined not less than 50,000 yuan but not more than 100,000 yuan; if a crime is constituted, it shall be investigated for criminal liability in accordance with the law; if losses are caused to another person, it shall bear the liability for compensation in accordance with the law.
Éú²úÆóÒµÔÚÐÂÊÞÒ©¼à²âÆÚÄÚ²»ÊÕ¼¯»òÕß²»¼°Ê±±¨Ë͸ÃÐÂÊÞÒ©µÄÁÆЧ¡¢²»Á¼·´Ó¦µÈ×ÊÁϵģ¬ÔðÁîÆäÏÞÆÚ¸ÄÕý£¬²¢´¦£±ÍòÔªÒÔÉÏ£µÍòÔªÒÔÏ·£¿î£»Çé½ÚÑÏÖصģ¬³·Ïú¸ÃÐÂÊÞÒ©µÄ²úÆ·Åú×¼Îĺš£    Any manufacturer that, during the period of surveillance of a new veterinary drug, fails to collect or to promptly submit the data concerning the therapeutic efficacy and adverse reactions of the drug shall be ordered to rectify within a time limit and shall, in addition, be fined not less than 10,000 yuan but not more than 50,000 yuan; if the circumstances are serious, the approval number of the product for the drug shall be revoked.
µ±ÊÂÈ˶ÔÊÞÒ©¼ìÑé½á¹ûÓÐÒìÒéµÄ£¬¿ÉÒÔ×ÔÊÕµ½¼ìÑé½á¹ûÖ®ÈÕÆ𣷸ö¹¤×÷ÈÕÄÚÏòʵʩ¼ìÑéµÄ»ú¹¹»òÕßÉϼ¶ÊÞÒ½ÐÐÕþ¹ÜÀí²¿ÃÅÉèÁ¢µÄ¼ìÑé»ú¹¹ÉêÇ븴¼ì¡£    Any party that objects to the testing result of a veterinary drug may, within seven working days from the date it receives the testing result, apply for a retest to the institution that did the testing or a test institution established by the administrative department for veterinary medicine at a higher level.
¶¯Îï²úÆ·µÄÉú²úÕß¡¢ÏúÊÛÕ߶Լì²â½á¹ûÓÐÒìÒéµÄ£¬¿ÉÒÔ×ÔÊÕµ½¼ì²â½á¹ûÖ®ÈÕÆ𣷸ö¹¤×÷ÈÕÄÚÏò×é֯ʵʩÊÞÒ©²ÐÁô¼ì²âµÄÊÞÒ½ÐÐÕþ¹ÜÀí²¿ÃÅ»òÕßÆäÉϼ¶ÊÞÒ½ÐÐÕþ¹ÜÀí²¿ÃÅÌá³öÉêÇ룬ÓÉÊÜÀíÉêÇëµÄÊÞÒ½ÐÐÕþ¹ÜÀí²¿ÃÅÖ¸¶¨¼ìÑé»ú¹¹½øÐи´¼ì¡£    Any producer or seller of animal products that objects to the detection results may, within seven working days from the date it receives the results, submit an application to the administrative department for veterinary medicine that arranges for the detection of the residue of veterinary drugs or the administrative department for veterinary medicine at the next higher level, and the administrative department for veterinary medicine that accepts the application shall designate a test institution for a retest.
µÚÒ»Ìõ ΪÁ˼ÓÇ¿ÊÞÒ©¹ÜÀí£¬±£Ö¤ÊÞÒ©ÖÊÁ¿£¬·ÀÖζ¯Îï¼²²¡£¬´Ù½øÑøÖ³ÒµµÄ·¢Õ¹£¬Î¬»¤ÈËÌ彡¿µ£¬Öƶ¨±¾ÌõÀý¡£    Article 1 These Regulations are formulated for the purpose of strengthening the administration of veterinary drugs, ensuring the quality of such drugs, preventing and controlling animal diseases, promoting the development of breeding industry, and safeguarding human health.
µÚÊ®Ìõ ¹ú¼Ò¶ÔÒÀ·¨»ñµÃ×¢²áµÄ¡¢º¬ÓÐл¯ºÏÎïµÄÊÞÒ©µÄÉêÇëÈËÌá½»µÄÆä×Ô¼ºËùÈ¡µÃÇÒδÅû¶µÄÊÔÑéÊý¾ÝºÍÆäËûÊý¾Ýʵʩ±£»¤¡£    Article 10 The State offers protection to the undisclosed test data and other data, accumulated by the applicant itself and submitted by it, which concern the veterinary drug that has been registered according to law and contains a new compound.
µÚʮһÌõ ÉèÁ¢ÊÞÒ©Éú²úÆóÒµ£¬Ó¦µ±·ûºÏ¹ú¼ÒÊÞÒ©ÐÐÒµ·¢Õ¹¹æ»®ºÍ²úÒµÕþ²ß£¬²¢¾ß±¸ÏÂÁÐÌõ¼þ£º    Article 11 A veterinary drug manufacturer shall be established in conformity with the national development programme and policy for the veterinary drug industry and shall meet the following requirements:
µÚÊ®¶þÌõ ÊÞÒ©Éú²úÐí¿ÉÖ¤Ó¦µ±ÔØÃ÷Éú²ú·¶Î§¡¢Éú²úµØµã¡¢ÓÐЧÆںͷ¨¶¨´ú±íÈËÐÕÃû¡¢×¡Ö·µÈÊÂÏî¡£    Article 12 In the Veterinary Drug Manufacturing Licence shall be clearly stated the scope and place of manufacturing, expiry date, the name and address of the legal representative, etc.
µÚÊ®ÈýÌõ ÊÞÒ©Éú²úÆóÒµ±ä¸üÉú²ú·¶Î§¡¢Éú²úµØµãµÄ£¬Ó¦µ±ÒÀÕÕ±¾ÌõÀýµÚʮһÌõµÄ¹æ¶¨ÉêÇë»»·¢ÊÞÒ©Éú²úÐí¿ÉÖ¤£¬ÉêÇëÈËƾ»»·¢µÄÊÞÒ©Éú²úÐí¿ÉÖ¤°ìÀí¹¤É̱ä¸üµÇ¼ÇÊÖÐø£»±ä¸üÆóÒµÃû³Æ¡¢·¨¶¨´ú±íÈ˵ģ¬Ó¦µ±ÔÚ°ìÀí¹¤É̱ä¸üµÇ¼ÇÊÖÐøºó£±£µ¸ö¹¤×÷ÈÕÄÚ£¬µ½Ô­·¢Ö¤»ú¹ØÉêÇë»»·¢ÊÞÒ©Éú²úÐí¿ÉÖ¤¡£    Article 13 Where intending to change its scope or place of manufacturing, a veterinary drug manufacturer shall apply for renewal of the Veterinary Drug Manufacturing Licence in accordance with the provisions of Article 11 of these Regulations, and the applicant shall, on the basis of the renewed Veterinary Drug Manufacturing Licence, complete the formalities for change of business registration; where intending to change the name of the enterprise or its legal representative, it shall, within 15 working days after it completes the formalities for change of business registration, apply to the original department that issued the licence for renewal of the Veterinary Drug Manufacturing Licence.
µÚÊ®ËÄÌõ ÊÞÒ©Éú²úÆóÒµÓ¦µ±°´ÕÕ¹úÎñÔºÊÞÒ½ÐÐÕþ¹ÜÀí²¿ÃÅÖƶ¨µÄÊÞÒ©Éú²úÖÊÁ¿¹ÜÀí¹æ·¶×éÖ¯Éú²ú¡£    Article 14 A veterinary drug manufacturer shall conduct production in accordance with the Good Manufacturing Practice for Veterinary Drugs laid down by the administrative department for veterinary medicine of the State Council.
µÚÊ®ÎåÌõ ÊÞÒ©Éú²úÆóÒµÉú²úÊÞÒ©£¬Ó¦µ±È¡µÃ¹úÎñÔºÊÞÒ½ÐÐÕþ¹ÜÀí²¿Ãź˷¢µÄ²úÆ·Åú×¼Îĺţ¬²úÆ·Åú×¼ÎĺŵÄÓÐЧÆÚΪ£µÄê¡£ÊÞÒ©²úÆ·Åú×¼Îĺŵĺ˷¢°ì·¨ÓɹúÎñÔºÊÞÒ½ÐÐÕþ¹ÜÀí²¿ÃÅÖƶ¨¡£    Article 15 To produce a veterinary drug, a veterinary drug manufacturer shall acquire an approval number for the product verified and issued by the administrative department for veterinary medicine of the State Council, and such approval number of the product is valid for five years. The measures for verifying and issuing such an approval number for the product shall be formulated by the administrative department for veterinary medicine of the State Council.
µÚÊ®ÁùÌõ ÊÞÒ©Éú²úÆóÒµÓ¦µ±°´ÕÕÊÞÒ©¹ú¼Ò±ê×¼ºÍ¹úÎñÔºÊÞÒ½ÐÐÕþ¹ÜÀí²¿ÃÅÅú×¼µÄÉú²ú¹¤ÒÕ½øÐÐÉú²ú¡£ÊÞÒ©Éú²úÆóÒµ¸Ä±äÓ°ÏìÊÞÒ©ÖÊÁ¿µÄÉú²ú¹¤Òյģ¬Ó¦µ±±¨Ô­Åú×¼²¿ÃÅÉóºËÅú×¼¡£    Article 16 A veterinary drug manufacturer shall conduct production in accordance with the national standards for veterinary drugs and the manufacturing process approved by the administrative department for veterinary medicine of the State Council. When intending to alter the manufacturing process that affects the quality of a veterinary drug, a veterinary drug manufacturer shall report the matter to the original approval department for verification and approval.
µÚÊ®ÆßÌõ Éú²úÊÞÒ©ËùÐèµÄÔ­ÁÏ¡¢¸¨ÁÏ£¬Ó¦µ±·ûºÏ¹ú¼Ò±ê×¼»òÕßËùÉú²úÊÞÒ©µÄÖÊÁ¿ÒªÇó¡£    Article 17 The substances and excipients used for the production of veterinary drugs shall be up to the national standards or the quality required for the veterinary drugs produced.
µÚÊ®°ËÌõ ÊÞÒ©³ö³§Ç°Ó¦µ±¾­¹ýÖÊÁ¿¼ìÑ飬²»·ûºÏÖÊÁ¿±ê×¼µÄ²»µÃ³ö³§¡£    Article 18 A veterinary drug shall be subject to quality test before it leaves the manufacturing plant, and it shall not be released if it does not conform to the quality standards.
µ±Ç°µÚ1Ò³ ¹²4Ò³ ÏÂÒ»Ò³ Ìøתµ½µÚ Ò³
| ÎÒÃǵijÐŵ | Òþ˽Õþ²ß | ÍøÕ¾µØͼ | ´ÊµäË÷Òý | ÉêÇëÁ´½Ó |
ºÏ×÷»ï°é£º Íò·½Êý¾Ý άÆÕ×ÊѶ ¶¯ÎïÓªÑøѧ±¨ ¸ü¶àºÏ×÷»ï°é
ÓÑÇéÁ´½Ó£º ½ðÈÚ·­Òë ²ÄÁÏ¿Æѧ·­Òë µØÖÊ·­Òë ҽѧ·­Òë µØÇò¿Æѧ·­Òë »·¾³·­Òë ÀíÂÛÓë½»²æ¿Æѧ·­Òë ÉúÎï·­Òë Å©Òµ·­Òë ÎïÀí·­Òë ÈËÎÄ¿Æѧ·­Òë
ÎÄÑÔÎÄ·­Òë ÐÄÀíѧ·­Òë ½ðÈÚ·­Òë ¹¤É̹ÜÀí·­Òë ·¨ÂÉ·­Òë ¾­¼Ã·­Òë ´«Ã½·­Òë ÐÂÎÅ·­Òë ±¨¸æ·­Òë ÍøÕ¾·­Òë ʯÓÍ·­Òë »úе·­Òë º½¿Õº½Ìì·­Òë
µçÐÅ·­Òë Ò½ÁÆÆ÷е·­Òë ÄÜÔ´·­Òë Ìú··­Òë »¯¹¤·­Òë ±êÊé·­Òë רÀû·­Òë Æû³µ·­Òë ÍÁľ¹¤³Ì·­Òë ½»Í¨·­Òë ¸Ö½á¹¹·­Òë Ë®Àû·­Òë ½¨Öþ·­Òë
¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡
Óï¼Ê·­Ò빫˾ °æȨËùÓÐ
Copyright © 2014   Beijing Cross Language Culture Communication Co., Ltd.    All Rights Reserved.
ICP±¸°¸ºÅ£º¾©ICP±¸09077047ºÅ-3